InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,900.00
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.26
(
-0.12%
)
Bitcoin
58,940.92
(
-2.85%
)
Post# of 6306
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pistol1p

Send PM Follow Ignore
Followers 14
Posts 535
Boards Moderated 0
Alias Born 10/15/2012

pistol1p

Re: Randolph Duke post# 2213

Friday, 05/02/2014 10:51:46 PM

Friday, May 02, 2014 10:51:46 PM

Post# of 6306
Frank Reynolds, the former CEO, pumped the company and the stock above the $5.50 mark last year.

He had been quoting a timeline for clinical trials and uplisting, which he was unable to deliver on. NVIV stock subsequently dropped below $1.50 pps and new management has the first clinical trial site almost ready to deploy the scaffolding into the first patient.

Good luck to all the longs.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up